ReviewCancers2023

Clinical Utility of Genomic Tests Evaluating Homologous Recombination Repair Deficiency (HRD) for Treatment Decisions in Early and Metastatic Breast Cancer.

Loïck Galland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.